Ruth M. Rothstein CORE Center Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Chicago Illinois United States (1998)

Organization Overview

First Clinical Trial
2005
NCT00227357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ruth M. Rothstein CORE Center